BJR
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lyubimova, N V
Right arrow Articles by Martin, R F
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lyubimova, N V
Right arrow Articles by Martin, R F
British Journal of Radiology 74 (2001),77-82 © 2001 The British Institute of Radiology

Short communication

In vivo radioprotection of mouse brain endothelial cells by Hoechst 33342

N V Lyubimova, PhD 1, P G Coultas, PhD 1 K Yuen, MSc 2 and R F Martin, PhD 1

1 Trescowthick Research Laboratories 2 Statistical Centre, Peter MacCallum Cancer Institute, St Andrews Place, Melbourne, Victoria 3000, Australia

Radiation-induced loss of mouse brain endothelial cells has been examined in mice given an intravenous injection of the DNA-binding radioprotector Hoechst 33342 (80 mg kg-1). At the time of irradiation, 10 min after injection, Hoechst fluorescence in the brain was confined to the endothelial cells. Endothelial cell density was measured using a histochemical fluorescence technique that had been used previously to monitor post-irradiation changes in endothelial cell density in rat brain, in which it was shown that a sensitive subpopulation comprising about 15% of the endothelial cells was lost within 24 h of radiation exposure. The present study shows a similar dose–response for the control mice, with depletion of the sensitive subpopulation to 85% being almost complete after a dose of 2.5 Gy {gamma}-rays. However, in mice irradiated 10 min after Hoechst 33342 administration, doses between 12 Gy and 20 Gy were required to ablate these cells. The kinetics of cell loss and the rather large dose modification factor suggests that Hoechst 33342 may be suppressing an apoptotic response in this subpopulation. Whatever the mechanism involved, Hoechst 33342 clearly provides substantial protection against early radiation-induced endothelial cell loss. Further studies are necessary to determine the extent to which this initial protection translates into an improved long-term survival of the "protected" cells and, especially, to see whether this endothelial cell protection can ameliorate the later consequences of central nervous system irradiation, namely necrosis and paralysis.




This article has been cited by other articles:


Home page
Br. J. Radiol.Home page
N Lyubimova and J W Hopewell
Experimental evidence to support the hypothesis that damage to vascular endothelium plays the primary role in the development of late radiation-induced CNS injury
Br. J. Radiol., June 1, 2004; 77(918): 488 - 492.
[Abstract] [Full Text] [PDF]


Home page
Nucleic Acids ResHome page
A. Adhikary, V. Buschmann, C. Muller, and M. Sauer
Ensemble and single-molecule fluorescence spectroscopic study of the binding modes of the bis-benzimidazole derivative Hoechst 33258 with DNA
Nucleic Acids Res., April 15, 2003; 31(8): 2178 - 2186.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
BJR DMFR IMAGING  ALL BIR JOURNALS 
Copyright © 2001 by the British Institute of Radiology.